The capacity of α2-macroglobulin to inhibit an exogenous protease is significantly increased in critically ill and septic patients

Shock

Volumn 22, Issue 1, 2004, Pages 16-22

  Schaefer, Ute ^a   Brücker, Beate ^a   Elbers, Andrea ^a   Neugebauer, Edmund ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Bromelain; Inflammation; Inhibitory capacity; Protease inhibitor

Indexed keywords

ALPHA 2 MACROGLOBULIN; BROMELAIN; GROWTH FACTOR; PROTEINASE; PROTEINASE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; ENZYME INHIBITION; FEMALE; HUMAN; MALE; MEDIATOR RELEASE; PATHOPHYSIOLOGY; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; SEPSIS; WESTERN BLOTTING; METABOLISM; MIDDLE AGED; REFERENCE VALUE;

ADULT; AGED; ALPHA-MACROGLOBULINS; BROMELAINS; CRITICAL ILLNESS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEASE INHIBITORS; REFERENCE VALUES; SEPSIS;

EID: 13644258360     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000130586.63862.27     Document Type: Article

References (47)

1. Abbink JJ, Nuijens JH, Eerenberg AJ, Huijbregts CC, Strack van Schijndel RJ, Thijs LG, Hack CE: Quantification of functional and inactivated alpha 2-macroglobulin in sepsis. Thromb Haemost 65:32-39, 1991.
2. Pixley RA, Zellis S, Bankes P, DeLa Cadena RA, Page JD, Scott CF, Kappelmayer J, Wyshock EG, Kelly JJ, Colman RW: Prognostic value of assessing contact system activation and factor V in systemic inflammatory response syndrome. Crit Care Med 23:41-51, 1995.
3. Khan MM, Shibuya Y, Kambara T, Yamamoto T: Role of alpha-2-macroglobulin and bacterial elastase in guinea-pig pseudomonal septic shock. Int J Exp Pathol 76:21-28, 1995.
4. Martinez-Brotons F, Oncins JR, Mestres J, Amargos V, Reynaldo C: Plasma kallikrein-kinin system in patients with uncomplicated sepsis and septic shock - comparison with cardiogenic shock. Thromb Haemost 58:709-713, 1987.
5. Wakita H, Furukawa F, Takigawa M: Thrombin and trypsin induce granulocyte-macrophage colony-stimulating factor and interleukin-6 gene expression in cultured normal human keratinocytes. Proc Assoc Am Physicians 109:190-207, 1997.
6. Fritz H, Jochum M, Geiger R, Duswald KH, Dittmer H, Kortmann H, Neumann S, Lang H: Granulocyte proteinases as mediators of unspecific proteolysis in inflammation: a review. Folia Histochem Cytobiol 24:99-115, 1986.
7. Kalter ES, Daha MR, ten Gate JW, Verhoef J, Bouma BN: Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock. J Infect Dis 151:1019-1027, 1985.
8. Aasen AO, Smith-Erichsen N, Amundsen E: Studies on pathological plasma proteolysis in patients with septicemia. Scand J Clin Lab Invest Suppl 178:37-45, 1985.
9. Bagge L, Haglund O, Wallin R, Borg T, Modig J: Differences in coagulation and fibrinolysis after traumatic and septic shock in man. Scand J Clin Lab Invest 49:63-72, 1989.
10. Miyoshi S, Narukawa H, Tomochika K, Shinoda S: Actions of Vibrio vulnificus metalloprotease on human plasma proteinase-proteinase inhibitor systems: a comparative study of native protease with its derivative modified by polyethylene glycol. Microbiol Immunol 39:959-966, 1995.
11. Barrett AJ, Starkey PM: The interaction of alpha 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism. Biochem J 133:709-724, 1973.
12. Pochon F: Some consequences of the covalent and non-covalent binding modes of plasmin with alpha 2-macroglobulin. Biochim Biophys Acta 915:37-45, 1987.
13. Van Leuven F, Cassiman JJ, Van Den Berghe H: Demonstration of an alpha2-macroglobulin receptor in human fibroblasts, absent in tumor-derived cell lines. J Biol Chem 254:5155-5160, 1979.
14. Birkenmeier G, Heidrich K, Glaser C, Handschug K, Fabricius EM, Frank R, Reissig D: Different expression of the alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein in human keratinocytes and fibroblasts. Arch Dermatol Res 290:561-568, 1998.
15. Petersen CM: Alpha 2-macroglobulin and pregnancy zone protein. Serum levels, alpha 2-macroglobulin receptors, cellular synthesis and aspects of function in relation to immunology. Dan Med Bull 40:409-446, 1993.
16. Bhattacharjee G, Asplin IR, Wu SM, Gawdi G, Pizzo SV: The conformation-dependent interaction of alpha 2-macroglobulin with vascular endothelial growth factor. A novel mechanism of alpha 2-macroglobulin/growth factor binding. J Biol Chem 275:26806-26811, 2000.
17. Webb DJ, Wen J, Karns LR, Kurilla MG, Gonias SL: Localization of the binding site for transforming growth factor-beta in human alpha2-macroglobulin to a 20-kDa peptide that also contains the bait region. J Biol Chem 273:13339-13346, 1998.
18. Kurdowska A, Alden SM, Noble JM, Stevens MD, Carr FK: Involvement of alpha-2-macroglobulin receptor in clearance of interleukin 8-alpha-2- macroglobulin complexes by human alveolar macrophages. Cytokine 12:1046-1053, 2000.
19. Hughes SR, Khorkova O, Goyal S, Knaeblein J, Heroux J, Riedel NG, Sahasrabudhe S: Alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation. Proc Natl Acad Sci USA 95:3275-3280, 1998.
20. Wu SM, Patel DD, Pizzo SV: Oxidized alpha2-macroglobulin (alpha2M) differentially regulates receptor binding by cytokines/growth factors: implications for tissue injury and repair mechanisms in inflammation. J Immunol 161:4356-4365, 1998.
21. Webb DJ, Weaver AM, Atkins-Brady TL, Gonias SL: Proteinases are isoform-specific regulators of the binding of transforming growth factor beta to alpha 2-macroglobulin. Biochem J 320:551-555, 1996.
22. Chu CT, Pizzo SV: alpha 2-Macroglobulin, complement, and biologic defense: antigens, growth factors, microbial proteases, and receptor ligation. Lab Invest 71:792-812, 1994.
23. Paterson RL, Webster NR: Sepsis and the systemic inflammatory response syndrome. J R Coll Surg Edinb 45:178-182, 2000.
24. Yamada F, Takahashi N, Murachi T: Purification and characterization of a proteinase from pineapple fruit, fruit bromelain FA2. J Biochem (Tokyo) 79:1223-1234, 1976.
25. Harrach T, Eckert K, Schulze-Forster K, Nuck R, Grunow D, Maurer HR: Isolation and partial characterization of basic proteinases from stem bromelain. J Protein Chem 14:41-52, 1995.
26. Castell JV, Friedrich G, Kuhn CS, Poppe GE: Intestinal absorption of undegraded proteins in men: presence of bromelain in plasma after oral intake. Am J Physiol 273:G139-G146, 1997.
27. Nuijens JH, Eerenberg-Belmer AJ, Huijbregts CC, Schreuder WO, Felt-Bersma RJ, Abbink JJ, Thijs LG, Hack CE: Proteolytic inactivation of plasma C1-inhibitor in sepsis. J Clin Invest 84:443-450, 1989.
28. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine [see comments]. Chest 101:1644-1655, 1992.
29. Birkenmeier G, Schuke HL, Briest S, Kopperschlager G: Determination of total and transformed alpha 2-macroglobulin by a monoclonal antibody immunosorption assay in patients with different diseases. Ann NY Acad Sci 737:425-427, 1994.
30. Barrett AJ, Brown MA, Sayers CA: The electrophoretically "slow" and "fast" forms of the alpha 2-macroglobulin molecule. Biochem J 181:401-418, 1979.
31. Strickland DK, Larsson LJ, Neuenschwander DE, Bjork I: Reaction of proteinases with alpha 2-macroglobulin: rapid-kinetic evidence for a conformational rearrangement of the initial alpha 2-macroglobulin-trypsin complex. Biochemistry 30:2797-2803, 1991.
32. Tortorella MD, Arner EC: A high-throughput assay for stromelysin using a casein-resorufin substrate. Inflamm Res 46(Suppl 2):S122-S123, 1997.
33. Arakawa H, Nishigai M, Ikai A: alpha 2-Macroglobulin traps a proteinase in the midregion of its arms, an immunoelectron microscopic study. J Biol Chem 264:2350-2356, 1989.
34. Castel H, Jegou S, Tonon MC, Vaudry H: Regulation of the GABA(A) receptor by nitric oxide in frog pituitary melanotrophs. Endocrinology 141:3451-3460, 2000.
35. Sottrup-Jensen L, Birkedal-Hansen H: Human fibroblast collagenase-alpha-macroglobulin interactions. Localization of cleavage sites in the bait regions of five mammalian alpha-macroglobulins. J Biol Chem 264:393-401, 1989.
36. Soker S, Svahn CM, Neufeld G: Vascular endothelial growth factor is inactivated by binding to alpha 2-macroglobulin and the binding is inhibited by heparin. J Biol Chem 268:7685-7691, 1993.
37. de Boer JP, Creasey AA, Chang A, Abbink JJ, Roem D, Eerenberg AJ, Hack CE, Taylor FB Jr: Alpha-2-macroglobulin functions as an inhibitor of fibrinolytic, clotting, and neutrophilic proteinases in sepsis: studies using a baboon model. Infect Immun 61:5035-5043, 1993.
38. Saso L, Leone MG, Mo MY, Grippa E, Cheng CY, Silvestrini B: Differential changes in alpha2-macroglobulin and hemopexin in brain and liver in response to acute inflammation. Biochemistry 64:839-844, 1999.
39. Chu CT, Pizzo SV: alpha 2-Macroglobulin, complement, and biologic defense: antigens, growth factors, microbial proteases, and receptor ligation. Lab Invest 71:792-812, 1994.
40. Wu SM, Pizzo SV: alpha(2)-Macroglobulin from rheumatoid arthritis synovial fluid: functional analysis defines a role for oxidation in inflammation. Arch Biochem Biophys 391:119-126, 2001.
41. Eastman HB, Fawcett TW, Udelsman R, Holbrook NJ: Effects of perturbations of the hypothalamic-pituitary-adrenal axis on the acute phase response: altered C/EBP and acute phase response gene expression in lipopolysaccharide-treated rats. Shock 6:286-292, 1996.
42. Khan MM, Shibuya Y, Nakagaki T, Kambara T, Yamamoto T: Alpha-2-macroglobulin as the major defence in acute pseudomonal septic shock in the guinea-pig model. Int J Exp Pathol 75:285-293, 1994.
43. Bolke E, Jehle PM, Hausmann F, Daubler A, Wiedeck H, Steinbach G, Storck M, Orth K: Preoperative oral application of immunoglobulin-enriched colostrum milk and mediator response during abdominal surgery. Shock 17:9-12, 2002.
44. Sun Z, Wang X, Deng X, Lasson A, Wallen R, Hallberg E, Andersson R: The influence of intestinal ischemia and reperfusion on bidirectional intestinal barrier permeability, cellular membrane integrity, proteinase inhibitors, and cell death in rats. Shock 10:203-212, 1998.
45. Umans L, Serneels L, Overbergh L, Stas L, Van Leuven F: alpha2-Macroglobulin- and murinoglobulin-1-deficient mice, a mouse model for acute pancreatitis. Am J Pathol 155:983-993, 1999.
46. van Vugt H, van Gool J, de Ridder L: Alpha 2 macroglobulin of the rat, an acute phase protein, mitigates the early course of endotoxin shock. Br J Exp Pathol 67:313-319, 1986.
47. Bazel S, Andrejko KM, Chen J, Deutschman CS: Hepatic gene expression and cytokine responses to sterile inflammation: comparison with cecal ligation and puncture sepsis in the rat. Shock 11:347-355, 1999.